GlassScriptPhysician profile
Raj K Goyal
NPI 1699768721
$5,455.89
in general payments reported to CMS, 2019-2025
28 companies · $1,027 in 2025
The $1,027 reported for 2025 was more than what 78% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $321 · 2021: $1,005 · 2022: $1,312 · 2023: $498 · 2024: $735 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,260.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,274.28 | 2021-2025 | |
| Sight Sciences, INC. | $755.71 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $514.33 | 2019-2025 | Unity, Centurion, Clareon Panoptix Pro |
| Abbott Laboratories | $447.20 | 2024-2025 | Ensite, Aveir, Gallant |
| Allergan, INC. | $409.35 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $266.41 | 2022-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Johnson & Johnson Surgical Vision, INC. | $211.32 | 2022-2024 | Tecnis Simplicity |
| Aerie Pharmaceuticals, INC. | $210.69 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $183.49 | 2023 | Sovereign Compact, Tecnis Simplicity |
| Novartis Pharmaceuticals Corporation | $171.07 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $161.73 | 2025 | Acthar |
| Carl Zeiss Meditec USA, INC. | $148.40 | 2022 | |
| New World Medical,INC. | $95.41 | 2024-2025 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Glaukos Corporation | $87.74 | 2024-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idosetr |
| Nova Eye, INC. | $64.05 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $60.61 | 2023-2024 | Iyuzeh |
| Ocular Therapeutix, INC. | $59.25 | 2024-2025 | Dextenza |
| Sun Pharmaceutical Industries INC. | $53.19 | 2019 | |
| Ivantis, INC | $51.78 | 2020 | |
| Tearlab Corp | $42.00 | 2023-2024 | Scoutpro Osmolarity System, Tearlab Osmolarity System |
| Carl Zeiss Meditec, INC. | $36.11 | 2024 | |
| Beaver-Visitec International, INC. | $31.16 | 2025 | |
| Biotissue Holdings INC. | $23.89 | 2021 | |
| Shire North American Group INC | $22.04 | 2019 | |
| Mallinckrodt Enterprises LLC | $21.90 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Dompe US, INC. | $18.86 | 2019 | |
| Optos, INC. | $14.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.